DJIA 17,704.06 -53.85 -0.30%
NASDAQ 4,995.01 -18.11 -0.36%
S&P 500 2,072.70 -4.72 -0.23%
market minute promo

AbbVie Inc. (NYSE: ABBV)

68.07 -0.44 (-0.64%)

Quote as of

company name or ticker

Recent Quotes

ABBV $68.09 -0.61%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $68.68
Previous Close $68.51
Daily Range $68.11 - $68.90
52-Week Range $51.37 - $70.76
Market Cap $108.4B
P/E Ratio 61.17
Dividend (Yield) $2.04 (3.0%)
Ex-Dividend Date
Dividend Pay Date
Volume 2,066,890
Average Daily Volume 11,271,250
Current FY EPS $4.27



AbbVie Inc. (ABBV) Description

AbbVie Inc. Website:

News & Commentary Rss Feed

3 Biotech Stocks to Buy As the Greek Tragedy Unfolds

Exelixis, Enanta Pharmaceuticals, and Isis Pharmaceuticals are three names in biotech I'm closely watching in case they fall as a result of the financial crisis in Greece.

WidePoint Corporation: Does A Samsung Contract Matter With Apple's Dominance In America

The Best Way To Judge Past Performance: Part 2

Premarket Biotech Digest: Geron's Sharp Gain, Bayer Essure AEs, Juno Moves Higher

Premarket Biotech Digest: Celgene-Juno, AbbVie Rx Data, FDA-Gilead Lawsuit

Enanta is growing thanks to collaborations.

Water-Logged And Getting Wetter: AbbVie (ABBV)

Evercore ISI Analyst Breaks Down Amgen's IPR Against AbbVie's Humira Formulation Patent

Noteworthy ETF Outflows: JKD, ABBV, USB, ABT

Better Dividend Stock: AbbVie or Johnson & Johnson?

AbbVie and Johnson & Johnson are widely recognized as top-tier dividend stocks. Here is a look at which one offers the better long-term prospects for income-seeking investors.

See More ABBV News...